Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-10

FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Inc.)

View source ↗

Summary

FDA approves a supplemental application for Amantadine Hydrochloride submitted by Strides Pharma Inc., updating its approval scope under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine hydrochloride (amantadine hydrochloride)

Snippet

SUPPL AP for AMANTADINE HYDROCHLORIDE (AMANTADINE HYDROCHLORIDE)